Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

VANCOUVER, BC, June 8, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will present at the Healthcare Virtual Conference presented by Maxim Group LLC and hosted by M-Vest, on June 20-22, 2023. Payton Nyquvest, … Read more

Trillium Community Health Plan Announces Request for Applications for 2023 Small Grants for Community Benefit Initiatives

Grants to be awarded to local organizations that advance health equity in Oregon EUGENE, Ore. and TIGARD, Ore., June 8, 2023 /PRNewswire/ — Trillium Community Health Plan (Trillium) announced today a Request for Applications (RFA) for 2023 Small Grants for Community Benefit Initiatives. All grant funding is designed to support projects that drive healthcare quality solutions … Read more

Global Lactobacillus Acidophilus Probiotics Market to Expand at a CAGR of 8.1% by 2031| Growth Market Reports

PUNE, India, June 8, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Global Lactobacillus Acidophilus Probiotics Market Segments – by Form (Solid, Liquid, and Powder), Application (Food & Beverages, Dietary Supplements, Animal Feed, and Others), Distribution Channel (Online Pharmacy, Retail Pharmacy, Hospital Pharmacy, and Supermarket/Hypermarket), and Region: Size, Share, Trends … Read more

Der Beitrag von Turacoz zum Bereich Medical Writing

UTRECHT, Niederlande und NEU-DELHI, 8. Juni 2023 /PRNewswire/ — Turacoz begrüßt die transformativen Auswirkungen der generativen KI in der medizinischen Kommunikation, indem es aktiv an relevanten Veranstaltungen sowohl mit Neueinsteigern als auch Fachleuten auf diesem Gebiet teilnimmt. Vor kurzem führte Dr. Namrata Singh, Gründer und Direktor der Turacoz Group, im Rahmen der 55. EMWA Conference in … Read more

Herramientas de Inteligencia Artificial Generativa:contribución de Turacoz al sector de la redacción médica

-Herramientas de Inteligencia Artificial Generativa que potencian las publicaciones científicas: La contribución de Turacoz al sector de la redacción médica UTRECHT, Países Bajos y NUEVA DELHI, 8 de junio de 2023 /PRNewswire/ — Turacoz adopta el impacto transformador de la IA generativa en las comunicaciones médicas participando activamente en eventos relevantes tanto con los recién llegados … Read more

Ophthalmic Lens Market size to grow by USD 14.3 billion from 2022 to 2027; the increasing prevalence of refractive errors to be a major driver

NEW YORK, June 8, 2023 /PRNewswire/ — The ophthalmic lens market is set to grow by USD 14.3 billion from 2022 to 2027. The market is expected to be progressing at a CAGR of 4.85% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall … Read more

Digital Science renforce son soutien à l’industrie pharmaceutique suite à l’acquisition d’OntoChem

Dans un océan d’informations, les solutions basées sur l’IA aideront à orienter la recherche et le développement dans l’industrie LONDRES et HALLE, Allemagne, 8 juin 2023 /PRNewswire/ — Digital Science entend jouer un rôle encore plus important dans la découverte de médicaments par l’industrie pharmaceutique, en aidant cette dernière à passer au crible une mer d’informations et … Read more

Rising Focus On Health And Fitness Will Drive The Coffee And Tea Market At A Growth Rate Of More Than 6% In The Forecast Period

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 LONDON, June 8, 2023 /PRNewswire/ — As per The Business Research Company’s Coffee And Tea Global Market Report 2023, the increasing focus of individuals towards health and fitness is expected to … Read more

Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma

Data demonstrate a significant 71% reduction in risk of disease progression or death in selinexor + bortezomib + dexamethasone (SVd) arm versus bortezomib + dexamethasone (Vd) arm in PI-naïve patients Data demonstrate a significant 47% reduction in risk of death with SVd versus Vd in multiple myeloma patients who are refractory to treatment with lenalidomide … Read more

Lotus Clinical Research Announces Strategic Partnership with Trialogics For Clinical Trial Software Services

Strategically growing CRO aligns with Trialogics to expand technology offerings NEW PROVIDENCE, N.J. and WILMINGTON, Del., June 8, 2023 /PRNewswire/ — Today, Lotus Clinical Research announced it has entered into a strategic partnership with Trialogics to strengthen their existing relationship and expand Lotus’ use of Trialogics’ clinical trial software offerings. This collaboration will build upon … Read more